TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
INMB Stock 12 Month Forecast
Average Price Target
$8.00
▲(316.67% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Inmune Bio in the last 3 months. The average price target is $8.00 with a high forecast of $8.00 and a low forecast of $8.00. The average price target represents a 316.67% change from the last price of $1.92.
Maxim Group Sticks to Their Buy Rating for Inmune Bio (INMB)Header: 'Rating:Buy 12-Month Target Price:$8.00' and Rating History shows 'Buy:$30.000 (2/13/25)' followed by 'Buy:$8.000 (7/02/25)'.
Raymond James Keeps Their Hold Rating on Inmune Bio (INMB)Raymond James analyst Gary Nachman reiterated a Market Perform rating on INmune Bio Inc. (NASDAQ: INMB).
Maxim Group Sticks to Their Buy Rating for Inmune Bio (INMB)Header: 'Rating:Buy 12-Month Target Price:$8.00' and Rating History shows 'Buy:$30.000 (2/13/25)' followed by 'Buy:$8.000 (7/02/25)'.
Raymond James Keeps Their Hold Rating on Inmune Bio (INMB)Raymond James analyst Gary Nachman reiterated a Market Perform rating on INmune Bio Inc. (NASDAQ: INMB).
trades and holding each position for 1 Month would result in 20.00% of your transactions generating a profit, with an average return of -14.13% per trade.
trades and holding each position for 3 Months would result in 13.33% of your transactions generating a profit, with an average return of -24.04% per trade.
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 6.67% of your transactions generating a profit, with an average return of -46.69% per trade.
trades and holding each position for 2 Years would result in 6.67% of your transactions generating a profit, with an average return of -60.97% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
INMB Analyst Recommendation Trends
Rating
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Strong Buy
8
6
3
3
2
Buy
0
0
0
0
0
Hold
3
4
2
1
1
Sell
0
0
0
0
0
Strong Sell
2
2
2
0
0
total
13
12
7
4
3
In the current month, INMB has received 2Buy Ratings, 1Hold Ratings, and 0Sell Ratings. INMB average Analyst price target in the past 3 months is 8.00.
Each month's total comprises the sum of three months' worth of ratings.
INMB Financial Forecast
INMB Earnings Forecast
Next quarter’s earnings estimate for INMB is -$0.27 with a range of -$0.35 to -$0.23. The previous quarter’s EPS was -$0.24. INMB beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year INMB has Performed in-line its overall industry.
Next quarter’s earnings estimate for INMB is -$0.27 with a range of -$0.35 to -$0.23. The previous quarter’s EPS was -$0.24. INMB beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year INMB has Performed in-line its overall industry.
INMB Sales Forecast
Next quarter’s sales forecast for INMB is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. INMB beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year INMB has Performed in-line its overall industry.
Next quarter’s sales forecast for INMB is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. INMB beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year INMB has Performed in-line its overall industry.
INMB Stock Forecast FAQ
What is INMB’s average 12-month price target, according to analysts?
Based on analyst ratings, Inmune Bio’s 12-month average price target is 8.00.
What is INMB’s upside potential, based on the analysts’ average price target?
Inmune Bio has 316.67% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is INMB a Buy, Sell or Hold?
Inmune Bio has a consensus rating of Moderate Buy which is based on 1 buy ratings, 1 hold ratings and 0 sell ratings.
What is Inmune Bio’s price target?
The average price target for Inmune Bio is 8.00. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $8.00 ,the lowest forecast is $8.00. The average price target represents 316.67% Increase from the current price of $1.92.
What do analysts say about Inmune Bio?
Inmune Bio’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of INMB?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.